-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OHGC3ELNDqUf3fl8Nk4kPA+FMuH24JxBq33FPGyrkBPzmFDUZtKL7ARNvN0hfISx VB67W0KDjtxT/wKfjqSzbQ== 0001305253-09-000003.txt : 20090910 0001305253-09-000003.hdr.sgml : 20090910 20090910134010 ACCESSION NUMBER: 0001305253-09-000003 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20090910 DATE AS OF CHANGE: 20090910 EFFECTIVENESS DATE: 20090910 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Celladon Corp CENTRAL INDEX KEY: 0001305253 IRS NUMBER: 330971591 STATE OF INCORPORATION: CA FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-69966 FILM NUMBER: 091062299 BUSINESS ADDRESS: STREET 1: 2223 AVENIDA DE LA PLAYA STREET 2: SUITE 300 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 858-366-4288 MAIL ADDRESS: STREET 1: 2223 AVENIDA DE LA PLAYA STREET 2: SUITE 300 CITY: LA JOLLA STATE: CA ZIP: 92037 D/A 1 primary_doc.xml X0502 D/A LIVE 0001305253 Celladon Corp 2223 AVENIDA DE LA PLAYA SUITE 300 LA JOLLA CA 92037 858-366-4288 None CALIFORNIA Corporation true Krisztina Zsebo 2223 Avenida de la Playa, Suite 300 La Jolla CA 92037 Executive Officer Director Rebecque Laba 2223 Avenida de la Playa, Suite 300 La Jolla CA 92037 Executive Officer Kenneth R. Chien 2223 Avenida de la Playa, Suite 300 La Jolla CA 92037 Director Asish Xavier 2223 Avenida de la Playa, Suite 300 La Jolla CA 92037 Director Andrew E. Senyei 2223 Avenida de la Playa, Suite 300 La Jolla CA 92037 Director Anthony B. Evnin c/o Venrock Associates 530 Fifth Avenue, 22nd Floor New York NY 10036 Director Pharmaceuticals Decline to Disclose 06 true 9999999997-08-017790 2008-03-19 false true true true false 0 24631114 21800002 2831112 Issuer may issue up to 13,666,668 shares of Series C Preferred Stock at $1.80 per share and warrants to purchase up to 3,111,112 shares of Series C Preferred Stock at an aggregate exercise price of $31,111.12. The warrants have not yet been exercised. false 6 0 0 0 false Celladon Corp Rebecque Laba Rebecque Laba VP, Finance & Administration 2009-09-10 -----END PRIVACY-ENHANCED MESSAGE-----